Genetic Characterization of a French Cohort of GNE‐mutation negative inclusion body myopathy patients with exome sequencing

Hereditary inclusion body myopathy (hIBM) refers to a group of clinically and genetically heterogeneous diseases. The overlapping histochemical features of hIBM with other genetic disorders lead to low diagnostic rates with targeted single‐gene sequencing. This is true for the most prevalent form of hIBM, GNEpathy. Therefore, we used whole‐exome sequencing (WES) to determine whether a cohort of clinically suspected GNEpathy patients undiagnosed by targeted GNE analysis could be genetically characterized.

[1]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[2]  D. Hamroun,et al.  The 2015 version of the gene table of monogenic neuromuscular disorders (nuclear genome) , 2014, Neuromuscular Disorders.

[3]  P. Ng,et al.  SIFT missense predictions for genomes , 2015, Nature Protocols.

[4]  W. Engel,et al.  Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis. , 1998, Current opinion in rheumatology.

[5]  C. Béroud,et al.  Comparing targeted exome and whole exome approaches for genetic diagnosis of neuromuscular disorders , 2015, Applied & translational genomics.

[6]  G. Rouleau,et al.  TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update , 2013, Human mutation.

[7]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[8]  Coverage analysis of lists of genes involved in heterogeneous genetic diseases following benchtop exome sequencing using the ion proton , 2016, Journal of Genetics.

[9]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[10]  D. Hamroun,et al.  The 2016 version of the gene table of monogenic neuromuscular disorders (nuclear genome) , 2015, Neuromuscular Disorders.

[11]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[12]  Hanns Lochmüller,et al.  A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. , 2005, American journal of human genetics.

[13]  N. Lévy,et al.  Novel Pathogenic Variants in a French Cohort Widen the Mutational Spectrum of GNE Myopathy , 2015, Journal of neuromuscular diseases.

[14]  G. Tedeschi,et al.  TARDBP gene mutations in south Italian patients with amyotrophic lateral sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  F. Chapon,et al.  Hereditary myopathy with early respiratory failure: occurrence in various populations , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[17]  S. Dimauro,et al.  A new muscle glycogen storage disease associated with glycogenin‐1 deficiency , 2014, Annals of neurology.

[18]  Thomas Sejersen,et al.  The Kinase Domain of Titin Controls Muscle Gene Expression and Protein Turnover , 2005, Science.

[19]  Magalie S Leduc,et al.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.

[20]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[21]  Tsviya Olender,et al.  The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy , 2001, Nature Genetics.

[22]  W. Gahl,et al.  GNE myopathy: New name and new mutation nomenclature , 2014, Neuromuscular Disorders.

[23]  Steven J. M. Jones,et al.  FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project. , 2014, American journal of human genetics.

[24]  Christophe Béroud,et al.  UMD‐Predictor: A High‐Throughput Sequencing Compliant System for Pathogenicity Prediction of any Human cDNA Substitution , 2016, Human mutation.

[25]  K. Claeys,et al.  Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget’s disease of bone and frontotemporal dementia , 2009, Neuromuscular Disorders.

[26]  J. Holton,et al.  Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies , 2007, Human mutation.

[27]  Christophe Béroud,et al.  Improving molecular diagnosis of distal myopathies by targeted next-generation sequencing , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[28]  N. Luquin,et al.  A novel TARDBP insertion/deletion mutation in the flail arm variant of amyotrophic lateral sclerosis , 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[29]  I. Richard,et al.  Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD) , 2008, Neuromuscular Disorders.

[30]  Yan Huang,et al.  An analysis of exome sequencing for diagnostic testing of the genes associated with muscle disease and spastic paraplegia , 2012, Human mutation.

[31]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .